Although long regarded as the gold standard for liver fibrosis staging in chronic hepatitis C (CHC), liver biopsy (LB) implies both the risk of an invasive procedure and significant variability. The a

Figshare2016-08-01 更新30

Diagnostic performances of LSM, FT and ELF and their suggested optimal cutoff values.

肝纤维化无创诊断

性能评估

Abbreviations: ELF, enhanced liver fibrosis; LSM, liver stiffness measurement; FT, FibroTest; AUROC, area under the receiver operating characteristics curve; CI, confidence interval; PPV, positive pre

NIAID Data Ecosystem30

Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C

肝纤维化无创诊断

肝炎临床评估

NIAID Data Ecosystem50

Parameters associated with the use of 3 laboratory indices of liver fibrosis calculated on data at the time of the initial liver biopsy prior to interferon-based therapy for differentiating moderate to advanced histological liver fibrosis (METAVIR F2–4) from mild liver fibrosis (METAVIR F0–1) of the liver on initial biopsy (n = 115).

肝纤维化无创诊断

临床预测模型

APRI, aspartate aminotransferase-platelet ratio index; AUROC, Area under the ROC curve; PPV, positive predictive value; NPV, negative predictive value.

NIAID Data Ecosystem30

MR measures of liver fibrosis (MRker)

资源简介：

相关数据集